BlueStar Global Investors LLC – Trademark Portfolio
Entity Type: 16
BlueStar Global Investors LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BIGI, ITEQ, BIGITECH, BLUESTAR, and BLUESTAR INDEXES. The owner is based in New York, NY.
4th Floor
1350 Avenue of the Americas
New York, NY 10019
Showing of trademarks Trademarks
Trademark Classifications
BlueStar Global Investors LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BlueStar Global Investors LLC have?
BlueStar Global Investors LLC has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 6 abandoned.
What trademark classes does BlueStar Global Investors LLC file in?
BlueStar Global Investors LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are BlueStar Global Investors LLC's most well-known trademarks?
BlueStar Global Investors LLC's registered trademark portfolio includes well-known marks such as BIGI, ITEQ, BIGITECH, BLUESTAR, and BLUESTAR INDEXES. These are among 6 currently registered trademarks in the portfolio.
What is BlueStar Global Investors LLC's trademark registration success rate?
BlueStar Global Investors LLC has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.